Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Hong Kong Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

2 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	1548 New Genscript Biotech	HK$9.95	8.9%	-35.8%	HK$21.3b	HK$22.68	PS2.7x	E112.9%	0%
	2268 WuXi XDC Cayman	HK$29.95	1.7%	-3.4%	HK$36.2b	HK$34.16	PE56.4x	E27.0%	n/a

Page 1 of 1